Literature DB >> 24626242

Temporomandibular disorder, facial pain and the need for high level information.

Paulo César Rodrigues Conti1, Leonardo Rigoldi Bonjardim2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24626242      PMCID: PMC3908758          DOI: 10.1590/1678-77572014ed001

Source DB:  PubMed          Journal:  J Appl Oral Sci        ISSN: 1678-7757            Impact factor:   2.698


× No keyword cloud information.
Dear Readers, Temporomandibular disorders (TMD), a subclassification of musculoskeletal disorders, comprise a group of clinical problems affecting the masticatory muscles, the temporomandibular joint (TMJ), surrounding tissues components and combinations of these problems. These musculoskeletal disorders can produce signs and symptoms such as: functional limitation or deviation of the jaw during mandibular movements, joint sounds and pain in the TMJ and/or in the masticatory muscles[2]. Important features of this process are to be aggravated by jaw function, to present muscle and TMJ tenderness to palpation that reproduces the patient's chief complaint and to have a correspondence between the increased pressure applied and the pain report. Pain related to TMD is a great clinical challenge in dentistry and represents a major cause of nondental pain in the orofacial region[7]. TMD is thought to have a multifactorial etiology, including physical[6], genetic[5] and psychosocial[3] factors. Regarding the evidence of associations between psychosocial factors and TMD, anxiety and depression have been extensively studied, however, little is known about the temporality between these conditions. To the best of our knowledge, a unique cohort study verified that depressive and anxiety symptoms should be considered as risk factors for TMD pain[4]. In this sense, in the current issue the Journal of Applied Oral Science (JAOS) brings a study that investigates the association between anxiety/depression and TMD in a homogeneous population of college students. In the original study, authors evaluated Physical Therapy students and included those with diagnosis of TMD. These subjects were investigated two times about state of anxiety and depression, mandibular function, clinical signs and electromyographic activity of masticatory muscles. The authors describe a correlation between anxiety/depression and some variables in subjects with TMD[1]. Readers should be alert to the study of other psychosocial variables such as lifestyle, optimism (positive construct), catastrophizing (negative construct) that have been less studied in relation to TMD pain, although there is evidence of its influence on pain perception. Additionally, the present issue of the journal brings out an overview of risk factors related to TMJ response to mandibular advancement surgery. Authors conducted a literature search in different databases, and according to selected studies, highlighted, among other aspects, that surgery was unable to influence TMJ with preexisting displaced discs and crepitus and that the rigidity of the fixation technique seemed to influence TMJ position and health. However, based on methodological problems found in many articles, more evidenced-based studies are required to understand the response of the TMJ after mandibular advancement surgery[8]. These two contributions are important to collaborate for a better understanding of the puzzle related to TMD etiology and possible risk factors. TMD and related Orofacial Pain are challenging fields in contemporary dentistry, and our profession is encouraged to search for evidence-based information such as these two articles found in the current issue of the JAOS. We hope you enjoy reading both papers and continue to disseminate the concept of evidence-based health care. In other words, high level information is needed to create a high level dental care. Our patients will be eternally greatful.
  7 in total

1.  Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Ronald Dubner; Eric Bair; Cristina Baraian; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Richard Ohrbach; Roger B Fillingim; Flora Mulkey; Yoly Gonzalez; Sharon Gordon; Henry Gremillion; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Joel D Greenspan; Charles Knott; William Maixner; Gary Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 3.  Differential diagnosis of temporomandibular disorders and other orofacial pain disorders.

Authors:  Jeffrey P Okeson; Reny de Leeuw
Journal:  Dent Clin North Am       Date:  2011-01

4.  Depressive and anxiety symptoms as risk factors for temporomandibular joint pain: a prospective cohort study in the general population.

Authors:  Stefan Kindler; Stefanie Samietz; Mohammad Houshmand; Hans Jörgen Grabe; Olaf Bernhardt; Reiner Biffar; Thomas Kocher; Georg Meyer; Henry Völzke; Hans-Robert Metelmann; Christian Schwahn
Journal:  J Pain       Date:  2012-11-08       Impact factor: 5.820

Review 5.  The many faces of the genetics contribution to temporomandibular joint disorder.

Authors:  M Oakley; A R Vieira
Journal:  Orthod Craniofac Res       Date:  2008-08       Impact factor: 1.826

6.  Is there an association between anxiety/depression and temporomandibular disorders in college students?

Authors:  Letícia Bojikian Calixtre; Bruno Leonardo da Silva Grüninger; Thais Cristina Chaves; Ana Beatriz de Oliveira
Journal:  J Appl Oral Sci       Date:  2014 Jan-Feb       Impact factor: 2.698

Review 7.  TMJ response to mandibular advancement surgery: an overview of risk factors.

Authors:  José Valladares-Neto; Lucia Helena Cevidanes; Wesley Cabral Rocha; Guilherme de Araújo Almeida; João Batista de Paiva; José Rino-Neto
Journal:  J Appl Oral Sci       Date:  2014 Jan-Feb       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.